The clinical pharmacology of angiotensin converting enzyme inhibitors in chronic heart failure
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 53 (2) , 187-197
- https://doi.org/10.1016/0163-7258(92)90008-n
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Effect of Captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failureJournal of the American College of Cardiology, 1991
- Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.Circulation Research, 1989
- CaptoprilDrugs, 1988
- Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research GroupPublished by American Medical Association (AMA) ,1988
- Circulating and tissue angiotensin systems.Journal of Clinical Investigation, 1987
- Placebo-Controlled Study of Lisinopril in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- A cooperative multicenter study of captopril in congestive heart failure: Hemodynamic effects and long-term responseAmerican Heart Journal, 1985
- Captopril in heart failure. A double blind controlled trial.Heart, 1984
- Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous systemThe American Journal of Cardiology, 1982